Antibacterial prophylaxis in dermatologic surgery: an evidence-based review

Area of Science:

• Dermatologic surgery
• Infectious disease prevention
• Antimicrobial stewardship

Background:

• Clean skin surgery typically has low infection rates, making routine antibacterial prophylaxis unnecessary.
• Potential adverse effects of prophylaxis include multidrug-resistant pathogens and anaphylaxis.
• Specific patient groups and surgical sites may warrant tailored prophylaxis guidelines.

Purpose of the Study:

• To review current recommendations and evidence regarding antibacterial prophylaxis in dermatologic surgery.
• To identify specific scenarios where prophylaxis might be considered.
• To highlight areas requiring further research, particularly for high-risk patients.

Main Methods:

• Review of existing literature and guidelines on surgical site infection (SSI) prophylaxis.
• Analysis of risk factors associated with SSIs in dermatologic procedures.
• Evaluation of evidence for topical agents, intraincisional antibacterials, and specialized dressings.

Main Results:

• Routine antibacterial prophylaxis is not recommended for most dermatologic surgery.
• Evidence for topical agents and honey/silver dressings in clean wounds is limited.
• Intraincisional antibacterials show potential but require more study.
• Prophylaxis guidelines exist for bacterial endocarditis and joint prosthesis infections in specific contexts.

Conclusions:

• Dermatologic surgery generally does not require routine antibacterial prophylaxis.
• High-risk patients (e.g., with diabetes) and specific procedures may benefit from further investigation into prophylaxis.
• Current guidelines address specific cardiac and orthopedic conditions but require adaptation for cutaneous surgery contexts.